---
title: "NP90726m Vedolizumab (Entyvio(r))"
ocid: "ocds-r6ebe6-0000835484"
canonical_url: "https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000835484"
markdown_url: "https://d3tenders.com/contract/ocds-r6ebe6-0000835484.md"
json_url: "https://d3tenders.com/contract/ocds-r6ebe6-0000835484.json"
source: "Public Contracts Scotland"
current_stage: "Award"
buyer: "THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS PUBLIC SERVICES DELIVERY SCOTLAND) (PSD SCOTLAND)"
published: "2026-07-01"
---

# NP90726m Vedolizumab (Entyvio(r))

Buyer: THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS PUBLIC SERVICES DELIVERY SCOTLAND) (PSD SCOTLAND)  
Current stage: Award  
OCID: ocds-r6ebe6-0000835484

[View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000835484)  
[Download OCDS JSON](https://d3tenders.com/contract/ocds-r6ebe6-0000835484.json)

## Summary

The Common Services Agency, trading as Public Services Delivery Scotland (PSD Scotland), has recently completed a procurement process titled "NP90726m Vedolizumab (Entyvio®)", aimed at supplying Vedolizumab to NHS Scotland. The process was conducted under a limited procurement method due to the medicine's exclusive intellectual property rights, aligning with the Public Contracts (Scotland) Regulations 2015. The procurement, classified under health and governed by public law, pertains to all entities established under the National Health Service (Scotland) Act 1978. The contract was officially awarded on 24th June 2026, with Takeda UK Limited acting as the sole supplier in a single-supplier framework agreement. This process aligns with a goods procurement category and eliminates the need for a call for competition.

This procurement represents significant opportunities for businesses particularly those engaged in pharmaceuticals and health technology sectors. The contract with an estimated value of £47,898,609 points to substantial growth potential through collaboration with large-scale governmental health organisations like NHS Scotland. This framework agreement is ideal for large pharmaceutical firms with exclusive rights to specific drugs, emphasising innovation and proprietary medicinal products. Companies positioned in strategic supply chains or those with capabilities to offer similar exclusive healthcare products may find viable avenues for entry into significant public contracts.

## Notice

Supply of Vedolizumab (Entyvio(r)) to NHS Scotland.

### Lot Information

Lot 1

The Framework Agreement is for the supply of Vedolizumab (Entyvio(r)) to NHS Scotland. The Authority has awarded this Framework as a single supplier framework per line to one (1) Framework Participant.

### Procurement Information

The medicine to be awarded to the framework agreement is protected by exclusive rights, including intellectual property rights, in line with Regulation 33(1)(b)(iii) of the Public Contracts (Scotland) Regulations 2015.

## Key Details

| Field | Value |
| --- | --- |
| Publication source | Public Contracts Scotland |
| Latest notice | https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=JUL559126 |
| Notice type | OJEU - F3 - Contract Award Notice |
| Procurement type | Framework |
| Procurement category | Goods |
| Procurement method | Limited |
| Procurement method details | Award procedure without prior publication of a call for competition |
| Tender suitability | Not specified |
| Awardee scale | Large |
| All stages | Award |

## Dates

| Field | Value |
| --- | --- |
| Publication date | 1 Jul 2026 |
| Submission deadline | Not specified |
| Future notice date | Not specified |
| Award date | 24 Jun 2026 |
| Contract period | Not specified |
| Recurrence | Not specified |

## Values

| Field | Value |
| --- | --- |
| Tender value | Not specified |
| Lots value | Not specified |
| Awards value | Not specified |
| Contracts value | £47,898,609 |

## Status

| Field | Value |
| --- | --- |
| Tender status | Complete |
| Lots status | Complete |
| Awards status | Not specified |
| Contracts status | Active |

## Buyer

| Field | Value |
| --- | --- |
| Main buyer | THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS PUBLIC SERVICES DELIVERY SCOTLAND) (PSD SCOTLAND) |
| Locality | EDINBURGH |
| Post town | Edinburgh |
| Postcode | EH12 9EB |
| Country | Scotland |
| ITL 1 | TLM Scotland |
| ITL 2 | TLM1 East Central Scotland |
| ITL 3 | TLM13 City of Edinburgh |
| Local authority | City of Edinburgh |
| Electoral ward | Drum Brae/Gyle |
| Westminster constituency | Edinburgh South West |
| Delivery location | TLM Scotland |

## Supplier

| Field | Value |
| --- | --- |
| Number of suppliers | 1 |
| Supplier names | TAKEDA |

## CPV Codes

### Divisions

- 33 - Medical equipments, pharmaceuticals and personal care products

### Codes

- 33600000 - Pharmaceutical products

## Release History

- 1 Jul 2026 at 00:00 - Award - OJEU - F3 - Contract Award Notice - https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=JUL559126
- 25 Jun 2026 at 00:00 - Award - OJEU - F15 - Voluntary Ex Ante Transparency Notice - https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=JUN558723

## Documents

- https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=JUN558723
  NP90726m Vedolizumab (Entyvio(r)) - Supply of Vedolizumab (Entyvio(r)) to NHS Scotland.
- https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=JUL559126
  NP90726m Vedolizumab (Entyvio(r)) - Supply of Vedolizumab (Entyvio(r)) to NHS Scotland.

## Notice URLs

- http://
- http://publicservicesdelivery.scot/about/procurement/
- https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000835484

## Provenance

This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000835484. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-r6ebe6-0000835484.json.